Preliminary clinical trial shows great promise for new multiple sclerosis treatment
Female hormone estriol reduces relapse rate by nearly 50 percent, UCLA neurologist reports
A study conducted by Dr. Rhonda Voskuhl, a UCLA neurologist, shows that combining estriol, a female hormone, with Copaxone, a medication currently used to treat multiple sclerosis, reduced the relapse rate of MS by nearly 50 percent with only one year of treatment. (more…)